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Abstract—High diastolic stiffness of failing myocardium results from interstitial fibrosis and elevated resting tension
(Fpassive) of cardiomyocytes. A shift in titin isoform expression from N2BA to N2B isoform, lower overall
phosphorylation of titin, and a shift in titin phosphorylation from N2B to N2BA isoform can raise Fpassive of
cardiomyocytes. In left ventricular biopsies of heart failure (HF) patients, aortic stenosis (AS) patients, and controls
(CON), we therefore related Fpassive of isolated cardiomyocytes to expression of titin isoforms and to phosphorylation
of titin and titin isoforms. Biopsies were procured by transvascular technique (44 HF, 3 CON), perioperatively (25 AS,
4 CON), or from explanted hearts (4 HF, 8 CON). None had coronary artery disease. Isolated, permeabilized
cardiomyocytes were stretched to 2.2-m sarcomere length to measure Fpassive. Expression and phosphorylation of titin
isoforms were analyzed using gel electrophoresis with ProQ Diamond and SYPRO Ruby stains and reported as ratio of
titin (N2BA/N2B) or of phosphorylated titin (P-N2BA/P-N2B) isoforms. Fpassive was higher in HF (6.10.4 kN/m2)
than in CON (2.30.3 kN/m2; P0.01) or in AS (2.20.2 kN/m2; P0.001). Titin isoform expression differed between
HF (N2BA/N2B0.730.06) and CON (N2BA/N2B0.390.05; P0.001) and was comparable in HF and AS
(N2BA/N2B0.590.06). Overall titin phosphorylation was also comparable in HF and AS, but relative phosphory-
lation of the stiff N2B titin isoform was significantly lower in HF (P-N2BA/P-N2B0.770.05) than in AS
(P-N2BA/P-N2B0.540.05; P0.01). Relative hypophosphorylation of the stiff N2B titin isoform is a novel
mechanism responsible for raised Fpassive of human HF cardiomyocytes. (Circ Res. 2009;104:780-786.)
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Diastolic left ventricular (LV) dysfunction importantlycontributes to heart failure (HF) with either reduced LV
ejection fraction (EF) (HFREF) or with normal LV ejection
fraction (HFNEF).1 In HFREF, diastolic LV dysfunction
correlates with exercise intolerance2; in HFNEF, diastolic LV
dysfunction is an essential diagnostic feature.3,4 Diastolic LV
dysfunction has usually been attributed to interstitial fibrosis
because of an imbalance between matrix metalloproteinases
and their tissue inhibitors.5,6 Recently high resting tension
(Fpassive) of cardiomyocytes has also been implicated in
diastolic LV dysfunction.7–9 Cardiomyocytes from patients
with HFNEF have higher Fpassive than cardiomyocytes from
patients with HFREF and cardiomyocytes from both HF
groups have higher Fpassive than cardiomyocytes from con-
trols (CON).7–9 In vitro administration of protein kinase (PK)A
to HF cardiomyocytes lowers their elevated Fpassive to the level
observed in CON cardiomyocytes,7,8 whereas Fpassive of CON
cardiomyocytes does not respond to PKA.7
Alterations in cardiomyocyte Fpassive have been attributed
to the giant cytoskeletal protein titin,8 which can modulate
Fpassive through isoforms shifts10–12 and phosphorylation sta-
tus.13–17 In explanted hearts of HFREF patients with ischemic
or nonischemic cardiomyopathy,10–12 myocardial titin iso-
form expression shifts from the stiff N2B to the compliant
N2BA isoform with a resultant rise of the N2BA/N2B ratio.
In pooled endomyocardial biopsy samples of HFNEF pa-
tients, the N2BA/N2B ratio is lower than in HFREF patients,8
and the corresponding higher expression of the stiff N2B
isoform could explain the higher Fpassive in HFNEF cardio-
myocytes. Correction of the high Fpassive of skinned HF
cardiomyocytes by PKA suggests a phosphorylation deficit of
titin or of other myofilamentary proteins to be also involved.
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Phosphorylation of the cardiac-specific N2B spring element
of titin by PKA reduces Fpassive of rat cardiomyocytes13 and
of rat cardiac myofibrils.14 This phosphorylation-induced
reduction of Fpassive is titin isoform–dependent, with the
largest effect observed in rat ventricular myocardium, which
has an N2BA/N2B ratio of 0.1, and the smallest effect in
bovine atrial myocardium, which has an N2BA/N2B ratio of
9.16 Apart from phosphorylation by PKA, the cardiac-
specific N2B spring element of titin can also be phosphory-
lated by PKG, with a similar reduction of cardiomyofibrillar
stiffness.15 Lower cardiomyocyte Fpassive after PKA or PKG
can result not only from phosphorylation of titin but also from
less diastolic actin–myosin interaction of weakly bound
crossbridges. An effect of weakly bound crossbridges on
cardiomyocyte Fpassive is unlikely in normal myocardium but
possible in failing myocardium because of its increased
myofilamentary calcium sensitivity.18,19
The present study investigates the importance for the high
Fpassive in HF cardiomyocytes of: (1) titin isoform expression;
(2) titin phosphorylation; (3) titin isoform phosphorylation;
(4) phosphorylation of other myofilamentary proteins; and (5)
formation of weakly bound crossbridges. All measurements
were performed using human LV myocardial samples derived
from transvascular biopsies, surgical biopsies, and explanted
hearts. Transvascular procurement allowed HF patients with
less advanced HF to be included in the study.
Patients and Methods
Patients
The HF group consisted of 48 patients and was composed of 2
subgroups: (1) 44 patients hospitalized for worsening HF (New York
Heart Association [NYHA] class IV) and referred for cardiac
catheterization and transvascular endomyocardial biopsy because of
suspicion of infiltrative or inflammatory myocardial disease; and (2)
4 patients with end-stage dilated cardiomyopathy referred for cardiac
transplantation. In all HF patients, coronary angiography revealed
absence of significant (50% luminal diameter reduction) coronary
artery stenoses and histological examination of the biopsies or of the
explanted hearts ruled out active inflammatory or infiltrative myo-
cardial disease. Treatment consisted of angiotensin converting en-
zyme inhibitors (48/48), diuretics (48/48) and -blockers (25/48).
The 44 HF patients referred for cardiac catheterization and endo-
myocardial biopsy consisted of 27 HFREF patients and of 17
HFNEF patients. Their hemodynamic data are listed in the Table.
The 4 HF patients referred for cardiac transplantation all had
HFREF. Their hemodynamic data were not included in the Table
because of the long time interval between hemodynamic evaluation
and cardiac transplantation. All patients with HFREF had a LVEF
45%. All patients with HFNEF satisfied the criteria for the
diagnosis of HFNEF as recently proposed in a consensus document
of the Heart Failure and Echocardiography associations of the
European Society of Cardiology.4
The CON group consisted of 15 patients and was composed of 3
subgroups: (1) 3 patients with normal LV function and major
ventricular arrhythmias; (2) 4 patients with normal LV function and
mitral stenosis; and (3) 8 explanted donor hearts. Transvascular LV
biopsies were obtained in the first subgroup. In the second subgroup,
perioperative transmural LV biopsies were obtained at the time of
mitral valve replacement. The endomyocardial portion of the trans-
mural biopsy was used to allow for comparison with the endomyo-
cardial biopsies of the HF patients. No patient had significant (50%
luminal diameter reduction) coronary artery disease. Donors did not
undergo hemodynamic evaluation before explantation and their
hemodynamic data were therefore not included in the Table.
The AS group consisted of 25 patients with significant and
symptomatic aortic valve stenosis (mean aortic valve area: 0.50.3
cm2). Patients had syncope, angina, and/or dyspnea (NYHA class
II). Their hemodynamic data are also listed in the Table. No patient
had significant (50% luminal diameter reduction) coronary artery
disease. In the AS group, LV myocardial samples were procured
perioperatively at the time of aortic valve replacement by transmural
biopsy. The endomyocardial portion of the transmural biopsy was
used to allow for comparison with the endomyocardial biopsies of
the HF patients.
The local ethics committee approved the study protocol. Written
informed consent was obtained, and there were no complications
related to catheterization or biopsy procurement.
Fpassive Measurements in Isolated Cardiomyocytes
Force measurements were performed in single, mechanically isolated
cardiomyocytes as described previously.7–9 Force measurements
were obtained in cardiomyocytes isolated from transvascular biop-
sies (CON: n3; HF: n25) and perioperative biopsies (CON: n4;
AS: n18). Biopsy samples (5 mg wet weight) were defrosted in
relaxing solution, mechanically disrupted and incubated for 5 min-
utes in relaxing solution supplemented with 0.2% Triton X-100 to
remove all membrane structures. Single cardiomyocytes were sub-
sequently attached with silicone adhesive between a force transducer
and a piezoelectric motor (2.70.4 cardiomyocytes per patient).
Sarcomere length of isolated cardiomyocytes was adjusted to
2.2 m. To assess the effect of PKA on the Fpassive, myocytes were
incubated for 40 minutes in relaxing solution supplemented with the
catalytic subunit of PKA (100 U/mL; Sigma, batch 12K7495) and
dithiothreitol (6 mmol/L; Sigma). To study the effect of PKG,
Fpassive measurements were also performed after incubation of HF
cardiomyocytes in relaxing solution containing PKG1 (0.1 U/mL;
Sigma, batch 034K1336), guanosine cGMP (10 mol/L, Sigma) and
dithiothreitol (6 mmol/L; Sigma). After 40 minutes of incubation
with PKG, Fpassive measurements were repeated. Thereafter, cardio-
myocytes were incubated with PKA, as described above, and their
Fpassive were reassessed. To study the contribution of the thin
filament to Fpassive, HF cardiomyocytes were incubated for 40
minutes with the actin-capping protein gelsolin (0.05 mg/mL; clone
FX-45, kindly provided by Prof Dr Henk Granzier [University of
Arizona, Tucson]20) and subsequently exposed to PKA. To investi-
gate the involvement of weak crossbridge interaction, Fpassive of HF
cardiomyocytes was also measured in relaxing solution containing
2,3-butanedione monoxime (BDM) (40 mmol/L for 5 minutes;
Sigma). Force values were normalized for myocyte cross-sectional
area.
Titin Isoform Separation
Titin isoform separation was performed in myocardial samples of 10
HF patients, 9 AS patients, and 8 CON subjects. For 6 HF patients,
the myocardial sample was procured by transvascular biopsy and for
4 HF patients the myocardial sample was derived from an explanted
heart. For all CON subjects, the myocardial sample was derived from
an explanted donor heart. Tissue samples were homogenized in 100
Table. Clinical and Hemodynamic Patient Data
CON
(n7)
AS
(n25)
HFNEF
(n17)
HFREF
(n27)
Age, yr 615 673 663 563
LVEF, % 653 652 614 282‡§¶
LVEDVI, mL/m2 757 564 825 1307‡§¶
LVEDP, mm Hg 111 211‡ 241† 222†
LVMI, g/m2 984 1326* 1135 1618‡¶
LV Stiff Mod, kN/m2 2.20.2 6.00.3† 6.10.7† 5.00.8
LVEDWS, kN/m2 2.90.2 4.00.3† 5.50.4† 8.70.7‡§¶
*P0.05 vs CON, †P0.01 vs CON, ‡P0.001 vs CON, §P0.001 vs AS,
¶P0.001 vs HFNEF.
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to 200 L Tris–sodium dodecyl sulfate buffer (pH 6.8) containing 8
g/mL leupeptin (Peptin-Institute, Japan) and phosphatase inhibitor
cocktails (PIC I [P2850] and PIC II [P5726], 10 L/mL from each;
Sigma). Samples were heated (3 minutes at 99°C) and centrifuged
(10 minutes, 13.000g at 0°C). Each sample (40 g dry weight) was
applied on agarose-strengthened 2% sodium dodecyl sulfate–poly-
acrylamide gels. The gel was run at 4-mA constant current for 16
hours. Gels were washed and stained with SYPRO Ruby (Molecular
Probes, Eugene, Ore) according to the instructions of the manufac-
turer. Staining was analyzed with a LAS-3000 system (Fuji Science
Imaging Systems) and AIDA Image analyzer software (Isotopen-
meßgera¨te GmbH, Staubenhardt, Germany).21
Myofilamentary Protein and Titin
Isoform Phosphorylation
Myofilamentary protein separation and phosphorylation were deter-
mined in myocardial samples procured by transvascular biopsy in 8
HF patients and by perioperative biopsy in 7 AS patients. Tissue was
dissolved in 1D sample buffer containing 100 mmol/L dithiothreitol,
PIC I, PIC II, and protease inhibitor cocktail (10 L/mL, P 8340,
Sigma), heated (3 minutes at 99°C) and centrifuged (10 minutes,
13.000 g at 0°C), and a sample (35 g dry weight in 25 L) was
applied on a 3% to 8% gradient gel (Criterion, Bio-Rad). The gel was
run at 100 V for 30 minutes followed by 200 V for 50 minutes. The
gels were stained for 90 minutes with ProQ Diamond (Molecular
Probes). Thereafter, the gels were washed and subsequently stained
with SYPRO Ruby (Molecular Probes).21 The intensity of the
myosin binding protein-C band was used to normalize for differences
in protein loading.
Titin isoform phosphorylation was determined in perioperative
biopsies of 9 AS patients and in transvascular biopsies of 6 HF
patients. Tissue samples were handled as for titin isoform separation.
The gels were subsequently stained with ProQ Diamond and with
SYPRO Ruby and analyzed as described above.
Statistical Analysis
Values are given as meansSEM. Statistical significance was set at
P0.05 and was obtained for multiple comparisons between groups
by ANOVA followed by a Bonferroni test. Relationships between 2
continuous variables were assessed with linear regression analysis.
Statistical analysis was performed with SPSS (version 9.0, SPSS Inc,
Chicago, Ill).
Results
Fpassive of Isolated Cardiomyocytes
Cardiomyocytes were isolated from myocardial samples of
the CON (n7), AS (n18), and HF (n25) groups and
stretched to an identical sarcomere length of 2.2 m before
measuring Fpassive (Figure 1a). Fpassive in HF cardiomyocytes
(6.10.4 kN/m2) was higher than in CON cardiomyocytes
(2.30.3 kN/m2; P0.01) or in AS cardiomyocytes (2.20.2
kN/m2; P0.001) (Figure 1b). Following administration of
PKA, the high Fpassive of HF cardiomyocytes fell (Figure 1c).
The high Fpassive of HF cardiomyocytes also fell on admin-
istration of PKG and remained unaltered on subsequent
treatment with PKA (Figure 1d). The high Fpassive of HF
cardiomyocytes was unaltered after 40 minutes of exposure to
gelsolin despite maximal Ca2 activated force falling below
10% of the baseline value. Subsequent administration of PKA
continued to induce a significant fall in Fpassive (P0.05;
n4). Gelsolin exposure confirms involvement of titin in the
high Fpassive because it removes the thin filament from the
cardiomyocytes.20 A contribution of crossbridge cycling to
Fpassive was ruled out by experiments exposing HF cardio-
myocytes to BDM. In these experiments BDM failed to alter
cardiomyocyte Fpassive (n4).
Titin Isoform Expression
Titin isoform expression was determined in myocardial sam-
ples of CON (n8), AS (n9) and HF patients (n10)
(Figure 2a). HF patients (0.730.06; P0.001) and AS
patients (0.590.06; P0.05) had an N2BA/N2B ratio
higher than the CON group (0.390.05) (Figure 2b). For 6
HF and all AS patients, myocardial biopsy occurred, respec-
tively, at the time of hemodynamic data acquisition or shortly
thereafter. Correlations between N2BA/N2B ratio and hemo-
dynamic variables were limited to this group. A significant
correlation (r0.71; P0.01) was observed between N2BA/
N2B ratio and LV end-diastolic wall stress (LVEDWS)
(Figure 2c).
Overall Titin Phosphorylation and Titin
Isoform Phosphorylation
Because titin isoform expression differed between HF and
CON, unequal titin isoform expression could have contrib-
uted to the difference in Fpassive between HF and CON
Figure 1. Measurement of cardiomyocyte Fpassive.
a, Single cardiomyocyte attached to a force trans-
ducer and an adjustable lever used to stretch the
cardiomyocyte to 2.2-m sarcomere length. b,
Higher Fpassive in cardiomyocytes of HF patients
compared to CON group (†P0.01 vs CON) and
AS patients (‡P0.001 vs AS). c, After in vitro
administration of PKA, Fpassive fell in HF cardio-
myocytes but not in CON and AS cardiomyocytes
(#P0.0001 vs HF). d, PKG administration also
significantly lowered Fpassive of HF cardiomyocytes
(##P0.0001 vs HF; n18); however, no further
decrease in Fpassive was detected on subsequent
PKA treatment.
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cardiomyocytes. However, because titin isoform expression
was comparable in HF and AS, mechanisms other than a titin
isoform shift had to account for raising Fpassive in HF
cardiomyocytes compared to AS cardiomyocytes. Overall
phosphorylation of titin was therefore compared between HF
and AS patients (Figure 3a). The ratio of phosphorylated titin
to total titin was similar in HF and AS samples (0.290.02
versus 0.300.02; P0.84). Similar ratios of phosphorylated
to total protein were also observed for myosin binding
protein-C (0.210.02 versus 0.260.03; P0.23), desmin
(0.350.05 versus 0.340.05; P0.93), troponin T
(0.480.04 versus 0.550.05; P0.32), and myosin light
chain-2 (0.270.02 versus 0.310.01; P0.09) (values in-
dicate HF versus AS, respectively) (Figure 3a). Only troponin
I had a lower ratio of phosphorylated to total protein in HF
compared to AS (0.120.01 versus 0.160.02; P0.048).
Because titin isoform expression and overall titin phos-
phorylation were comparable in HF and AS patients, the
phosphorylation status of the respective N2BA and N2B titin
isoforms was subsequently investigated in myocardial sam-
ples of HF and AS patients (Figure 3b). The P-N2BA/P-N2B
ratio was higher in HF (0.770.05) than in AS (0.540.05;
P0.01) (Figure 3c), consistent with lower phosphorylation
of the stiff N2B and higher phosphorylation of the compliant
N2BA titin isoform. Lower phosphorylation of N2B explains
the elevated Fpassive of HF cardiomyocytes because titin
phosphorylation was previously shown to lower Fpassive in an
isoform-dependent manner, with a larger fall in Fpassive when
more of the stiff N2B isoform was phosphorylated.16 The
P-N2BA/P-N2B ratio correlated with the N2BA/N2B ratio in
AS patients (r0.68; P0.05) (Figure 3d). This correlation
was absent in HF patients.
HFNEF Versus HFREF
In previous studies, Fpassive was especially elevated in cardio-
myocytes isolated from LV myocardium of HFNEF pa-
tients.7–9 Fpassive, titin isoform expression and titin isoform
phosphorylation were therefore compared in subgroups of
HFNEF and HFREF patients (Figure 4a through 4e), whose
hemodynamic characteristics are shown in the Table. HFREF
patients had the highest N2BA/N2B ratio (0.770.07) (Fig-
ure 4b). LVEDWS was also highest in HFREF (8.70.7
kN/m2) (Figure 4c). Fpassive (7.40.7 kN/m2) and the PKA-
induced decrease in Fpassive (3.20.6 kN/m2) were largest
in HFNEF (Figure 4d). Fpassive and the PKA-induced absolute
change in Fpassive rose from AS to HFREF and to HFNEF
(Figure 4e) (P0.05 for trend). The deficit of N2B titin
isoform phosphorylation followed a similar course also
rising from AS to HFREF and to HFNEF (Figure 4e)
(P0.05 for trend). The deficit was expressed as the difference
between observed P-N2BA/P-N2B ratio and predicted P-N2BA/
P-N2B ratio. The predicted P-N2BA/P-N2B ratio was derived
from the observed N2BA/N2B ratio and the equation describing
the linear curve fit of Figure 3d. A larger N2B titin isoform
phosphorylation deficit in HFNEF patients explains both their
higher Fpassive and their larger PKA-induced fall of Fpassive.
Discussion
High Fpassive of HF Cardiomyocytes and Titin
In the present study, Fpassive was twice as high in human HF
cardiomyocytes than in human AS cardiomyocytes. The high
Fpassive of HF cardiomyocytes fell after in vitro administration
of PKA or PKG but remained unchanged after in vitro
administration of BDM or gelsolin. The PKA- and PKG-
induced decrease in Fpassive suggested a phosphorylation
deficit of myofilamentary proteins, which are a target for both
PKA and PKG. Only troponin I and titin have so far been
identified as myofilamentary proteins targeted by both PKA
and PKG.15,22 The present study observed a phosphorylation
deficit of troponin I in HF myocardium. The concomitant
increase in myofilamentary calcium sensitivity could promote
diastolic actin–myosin interaction and thereby raise Fpassive in
HF cardiomyocytes.19 Such an effect of weakly bound cross-
bridges on Fpassive was however ruled out by the unchanged
Fpassive following exposure to BDM, which inhibits cross-
bridge cycling. Involvement of the giant cytoskeletal protein
titin in the high Fpassive of HF cardiomyocytes was suggested
by unaltered Fpassive after gelsolin, which removes the thin
filament from the cardiomyocytes.20,23,24 Effective thin fila-
ment removal was evident from the fall in maximal Ca2
activated force to less than 10% of its baseline value. The
ability of PKA to lower Fpassive after thin filament removal
Figure 2. Titin isoform expression. a, Representative examples
of titin isoform separation. b, Higher N2BA/N2B ratio in HF and
AS patients than in the CON group (†P0.05 vs CON). c, Corre-
lation between N2BA/N2B ratio and LVEDWS (r0.71; P0.01).
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implied phosphorylation of titin to mediate the PKA-induced
fall in Fpassive.
The present study observed titin isoform expression to be
comparable in HF and AS myocardium. Mechanisms other
than a titin isoform shift therefore had to account for the
difference in Fpassive between HF and AS cardiomyocytes.
Overall titin phosphorylation was also similar in HF and AS
myocardium. However, relative titin isoform phosphorylation
was different, with less N2B isoform phosphorylated in HF
than in AS myocardium. Less N2B titin isoform phosphory-
lation was previously shown to raise Fpassive,16 and the
observed hypophosphorylation of the stiff N2B titin isoform
relative to the compliant N2BA titin isoform could therefore
explain the higher Fpassive in HF cardiomyocytes.
Titin Isoform Expression
In a subgroup of HF and AS patients, hemodynamic data
were obtained either at the time of transvascular biopsy or
shortly before perioperative biopsy. In these patient groups,
myocardial titin isoform expression could accurately be
correlated with hemodynamic variables. The closest correla-
tion observed was between N2BA/N2B ratio and LVEDWS
(Figure 2c). The higher expression of the compliant N2BA
titin isoform at higher LVEDWS implies titin isoform shifts
to be a compensatory mechanism whereby higher expression
of the compliant N2BA titin isoform compensates for an
elevated LVEDWS. A compensatory role of titin isoform
shifts has previously also been suggested in patients with
dilated cardiomyopathy, in whom the N2BA/N2B ratio cor-
related with the LV end-diastolic volume/pressure ratio, a
measure of end-diastolic LV distensibility, and with peak
oxygen consumption during exercise.11 The time span over
which LVEDWS rises is probably an important determinant
for shifts in titin isoform expression because 2 canine dilated
cardiomyopathy models with rapid elevation of LVEDWS
induced by pacing tachycardia or by intracoronary microem-
bolizations revealed an opposite shift with overexpression of
the stiff N2B titin isoform.25–27 Furthermore, the correlation
observed in the present study between N2BA/N2B ratio and
LVEDWS is also consistent with stress-sensing abilities of
titin. Stress-sensing abilities of titin reside both in its kinase
domain at the M-line28 and in the titin/Tcap/muscle LIM
protein complex at the Z-disc.29
Titin Isoform Phosphorylation
Higher Fpassive in HF than in AS cardiomyocytes was attrib-
uted to a shift in isoform phosphorylation with more of the
N2BA and less of the N2B titin isoform phosphorylated in
HF myocardium. Previous studies indeed demonstrated less
reduction in Fpassive when the compliant N2BA titin isoform
is phosphorylated than when the stiff N2B titin isoform is
phosphorylated.16 The present study not only observed higher
N2BA titin isoform phosphorylation in HF myocardium but
also a loss in HF myocardium of the close relationship
between titin isoform expression and titin isoform phosphor-
ylation, which was present in AS myocardium (Figure 3d).
The uniformly low Fpassive observed in AS cardiomyocytes
despite the N2BA/N2B titin isoform ratio ranging from 0.4 to
0.9 (Figure 3d), probably resulted from the concordant
changes in titin isoform expression and phosphorylation in
AS myocardium, whereby higher N2B titin isoform phos-
phorylation offsets a rise of Fpassive induced by higher N2B
titin isoform expression. In HF myocardium, this concor-
dance between titin isoform expression and phosphorylation
Figure 3. Overall titin and titin isoform phosphory-
lation. a, Comparison between a representative AS
and HF patient of phosphorylation of myofilamen-
tary proteins using sequential gel electrophoresis
with ProQ Diamond phosphoprotein and SYPRO
Ruby protein stain. b, Comparison between a rep-
resentative AS and HF patient of phosphorylation
of titin isoforms using sequential gel electrophore-
sis with SYPRO Ruby and ProQ Diamond phos-
phoprotein stain. c, Higher P-N2BA/P-N2B ratio in
HF than in AS (*P0.01). d, Correlation between
P-N2BA/P-N2B ratio and N2BA/N2B ratio in AS
patients (r0.68; P0.05). All HF patients fell
above the regression line.
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was absent. This could be of special relevance to HFNEF
myocardium, which had higher N2B titin isoform expression
(Figure 4b) and a larger N2B titin isoform phosphorylation
deficit (Figure 4e). The latter explained both the larger Fpassive
and the larger response of Fpassive to PKA in HFNEF
cardiomyocytes (Figure 4e).
A shift in titin isoform phosphorylation, as demonstrated in
the present study in HF myocardium, can be explained by
spatial separation of phosphorylation sites on the N2BA and
N2B titin isoforms and by changes in compartmentalized
activities of protein kinases and phosphodiesterases.30,31 The
N2B unique sequence contains the phosphorylation site,
which mediates the fall in Fpassive.13,15,32 Immunoelectron
micrographs with antibody labeling C-terminal N2B unique
sequence revealed the site to be closer to the Z-disc in the
N2BA isoform than in the N2B isoform.26 PKA is targeted by
A-kinase anchoring proteins (AKAP) to transverse tubules,30
which are also adjacent to the Z disc. In HF, this targeting of
PKA by AKAP is disrupted,33 and this leads to a fall in
phosphorylation of surrounding myofilamentary proteins.30
The shift in titin isoform phosphorylation in HF myocardium
could result from altered local availability of not only cAMP
but also cGMP because in mouse, cardiac muscle phospho-
diesterase 5 activity is also highly compartmentalized.34
Conclusions
Because of comparable expression of titin isoforms and
similar overall phosphorylation of titin, the 2-fold rise in
Fpassive of HF cardiomyocytes compared to AS cardiomyo-
cytes was attributed to a shift in titin isoform phosphorylation
with relative hypophosphorylation of the stiff N2B titin
isoform. Relative hypophosphorylation of the stiff N2B titin
isoform is a novel mechanism responsible for raising Fpassive
in human HF cardiomyocytes. High cardiomyocyte Fpassive is
an important contributor to the high diastolic LV stiffness of
the failing heart, and the present findings could therefore have
important therapeutic implications.
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